Change - Announcement of Cessation::Announcement of Cessation
Issuer & Securities
TIANJIN ZHONG XIN PHARM GROUP
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Announcement of Cessation
Submitted By (Co./ Ind. Name)
Secretary to the Board
Description (Please provide a detailed description of the event in the box below)
Announcement of Cessation of Chairman of the Board of Directors
Name Of Person
Wang Zhi Qiang
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Job assignment change
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chairman of the Board of Directors
Role and responsibilities
Duties as Chairman of the Board of Directors
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Past (for the last 5 years)